Stuart Kaplan, OD
NPI 1790776219 · Optometrist · Cape Coral, FL
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790776219
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- OD
- Sex
- Male
- Sole proprietor
- No
- License
- OPC 3653 (FL)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
3,108 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Photography of the Retina92250 | 929 | $37 |
| Established Patient Complete Exam of Visual System92014 | 864 | $124 |
| Exam of the Internal Drainage System of Eye92020 | 342 | $27 |
| New Patient Complete Exam of Visual System92004 | 219 | $147 |
| Photography of Content of Eyes92285 | 214 | $23 |
| Established Patient Problem Focused Exam of Visual System92012 | 198 | $88 |
| Exam of Visual Field With Extended Testing |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 289 | 87 |
| Erythromycin Basebrand: Erythromycin | 280 | 218 |
| Timolol Maleate | 102 | 40 |
| Cyclosporinebrand: Restasis | 82 | 32 |
| Cephalexin | 48 | 46 |
| Lifitegrastbrand: Xiidra | 35 | 13 |
| Azithromycin | 28 | 25 |
| Dorzolamide Hcl/Timolol Maleat |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,335 across 22 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-03
- Last updated
- 2020-09-01
- Certified
- 2020-09-01
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.